Each chapter pairs the clinical story with a changing visual essay—original anatomical studies where precision helps and public-domain Renaissance masterworks where art says it better.
In briefFour concise answers from this dossier+
What is Injectables, Reframed?
Anatomy-led applications for expression, contour and proportion—designed to preserve the face in motion. Neuromodulators and fillers do different jobs. One addresses selected muscle activity; the other supports volume and contour. Consultation is about the whole face, not a syringe or trend. Candidacy and planning require consultation.
What does Injectables, Reframed address?
Facial injectables work in different layers: neuromodulators reduce selected muscle activity, hyaluronic-acid fillers support contour, and biostimulators encourage gradual collagen response. Neuromodulators and fillers do different jobs. One addresses selected muscle activity; the other supports volume and contour. Candidacy and planning require consultation.
How may Injectables, Reframed be performed?
Expression mapping before neuromodulator placement. Supportive rather than line-chasing filler placement. Product and depth selected for anatomy. Staged correction to avoid overfilling Neuromodulators and fillers do different jobs. One addresses selected muscle activity; the other supports volume and contour. Candidacy and planning require consultation.
What should I know about recovery, risks and alternatives?
Redness, tenderness, swelling and bruising may occur. Neuromodulator effect develops over days; filler swelling settles before final assessment. Asymmetry, eyelid or brow effects, nodules, infection, migration and vascular occlusion. Rare filler vascular events can cause skin injury, vision loss or stroke. Candidacy and planning require consultation.
Educational information only. These summaries cannot determine candidacy, diagnose a condition or replace an individual medical evaluation.
Portrait · purpose · possibility
Injectables, Reframed · the individual anatomy and goal
The opening portrait keeps the discussion grounded in the feature, proportion or concern this service is designed to evaluate.
The Dagan Edit
Overview
Injectables, Reframed
Neuromodulators and fillers do different jobs. One addresses selected muscle activity; the other supports volume and contour. Consultation is about the whole face, not a syringe or trend.
01Expression lines and brow balance
02Cheek, temple and midface support
03Lip shape and facial proportion
04Chin, profile and jawline refinement
1 of 7
DAGAN MD
Dagan MD · Procedure monograph
Injectables, Reframed
Anatomy-led applications for expression, contour and proportion—designed to preserve the face in motion.
Tal Dagan, MD, FACS · 420 Madison Avenue, Suites 503–505 · New York, NY 10017 · (212) 585-3242 · myfacesurgeon.com
Portrait · purpose · possibility Injectables, Reframed · the individual anatomy and goal The opening portrait keeps the discussion grounded in the feature, proportion or concern this service is designed to evaluate.
Overview
Injectables, Reframed
Neuromodulators and fillers do different jobs. One addresses selected muscle activity; the other supports volume and contour. Consultation is about the whole face, not a syringe or trend.
01Expression lines and brow balance
02Cheek, temple and midface support
03Lip shape and facial proportion
04Chin, profile and jawline refinement
Observation - anatomy - restraint Assessment before treatment: anatomy, movement and proportion The consultation scene reflects the first principle of injectable treatment: understand the face at rest and in motion before choosing a product, treatment plane or dose.
Prepare
Preparing thoughtfully
A well-planned procedure begins before treatment day.
01Review medications, allergies, pregnancy status, prior injections, dental work and skin infection history.
02Avoid unapproved blood-thinning supplements and schedule around major events according to the clinician’s guidance.
03Arrive with clean skin and realistic goals.
Movement - expression - balance Expression follows a map of muscular movement The flowing lines visualize how repeated muscle activity shapes expression. Neuromodulator treatment is planned selectively so lines can soften without erasing individuality.
Procedure
Botox®: expression in balance
Botox® is a neuromodulator that selectively relaxes overactive muscles. It can soften expression lines, help prevent repeated movement from deepening certain wrinkles and create a refreshed appearance while preserving natural expression.
01Expression lines and forehead wrinkles
02Frown lines between the brows
03Crow's feet around the eyes
04Brow balance and subtle shaping
05Jaw slimming for selected overactive masseter muscles
06Selected vertical neck bands
Movement - structure - long-term harmony How the plan may be tailored The planning map places each treatment decision within the whole face, reinforcing a conservative philosophy that values proportion, expression and long-term harmony over visible intervention.
Techniques
How the plan may be tailored
Every face has a different story of aging. Rather than following a standard injection pattern, treatment is customized according to anatomy, facial movement, volume loss, skin quality and facial proportions.
My philosophy is simple: beautiful results should be noticed because you look well—not because anyone notices you had treatment.
01Movement before volume — Wrinkles created by facial movement are approached differently than those caused by volume loss.
02Treat structure—not just lines — Volume is restored where facial support has diminished rather than simply filling individual wrinkles.
03The right product in the right place — Each filler behaves differently. Product selection, injection depth and placement are customized to your anatomy.
04Natural over noticeable — The best injectable treatment should rarely announce itself. The goal is refreshed facial balance—not exaggerated lips, overfilled cheeks or an artificial appearance.
05Less is often more — Conservative treatment allows gradual refinement while preserving natural facial expression and avoiding overcorrection.
06Long-term facial harmony — Every treatment is planned not only for today's result, but for how your face will continue to age over time.
Recovery - protection - refinement Healing unfolds with patience and time The botanical portrait reflects recovery as a gradual process: early swelling settles, tissues adapt and the result becomes softer and more natural with time.
Recovery
Healing is a Sequence
The result of facial injectables evolves gradually. Following a few guiding principles helps ensure a smooth recovery and beautiful, natural-looking outcome.
01Swelling is expected — Mild swelling, tenderness, redness or bruising is normal and usually resolves within several days.
02Protect your result — Avoid strenuous exercise, excessive heat, alcohol and unnecessary pressure on the treated areas during the recommended recovery period.
03Allow treatments to mature — Neuromodulators require several days to develop their full effect, while fillers gradually soften, integrate and settle into the surrounding tissues.
04Follow your personalized aftercare — Recovery instructions are tailored to your treatment, anatomy and the products used to optimize both healing and longevity.
05Natural results emerge with time — The most refined outcomes are not immediate. As swelling subsides and tissues adapt, facial balance and contour continue to improve.
Exceptional results are rarely created in a single day. They emerge through thoughtful planning, meticulous technique, and the quiet progression of healing.
Judgment · strategy · alternatives Portrait of Niccolò Machiavelli · Santi di Tito · Palazzo Vecchio · public domain Good decisions come from seeing choices clearly: benefits, limitations, risks and the wisdom to choose an alternative when it serves better.
Risks + alternatives
An informed decision
Every procedure has limitations and alternatives. Consultation should make both clear.
Risks to discuss
Asymmetry, eyelid or brow effects, nodules, infection, migration and vascular occlusion.
Rare filler vascular events can cause skin injury, vision loss or stroke.
Alternatives to consider
No treatment
Skin care and resurfacing
Fat transfer
Surgery when tissue descent or skeletal anatomy is the main concern
Inquiry · dialogue · understanding The School of Athens · Raphael · Vatican Museums · public domain The best consultation is a dialogue. Questions turn information into understanding and help make the plan genuinely personal.
Questions
Questions worth asking
Start with the indication: the precise anatomical or functional finding the procedure is intended to treat—and why that approach fits better than the alternatives.
What findings would make me a candidate for Injectables, Reframed?
Injectables are chosen according to the problem being treated: a neuromodulator for lines created by muscle movement, hyaluronic-acid filler for selected volume or contour deficits, and a biostimulator for broader collagen-related support. They are not interchangeable and are poor substitutes for surgery when tissue has substantially descended. The indication should name the anatomical target, product category and intended change before treatment begins.
What can this procedure realistically change?
The indication above defines the anatomical problem the procedure can address. It cannot promise symmetry, stop aging or correct concerns that arise from a different tissue layer.
When will I see the final result?
Timing varies by procedure and healing; early swelling, firmness or asymmetry should not be mistaken for the final contour.
Educational information only. Not medical advice. Consultation is required for individualized recommendations. Candidacy, technique, risks, recovery and alternatives require an individual examination. Illustrations do not predict or guarantee a result.
Educational information only. Candidacy, technique, risks, recovery and alternatives require an individual examination. Illustrations do not predict or guarantee a result.
The Anatomy Theater
Surgery happens in layers.
Turn the licensed anatomical study, then descend from skin to facial fat, muscle, and the bone-and-cartilage framework. This is an educational model—not a scan, diagnosis, or simulation.
Selected layerFacial fat compartmentsThe source model contains fifteen named facial fat compartments, including cheek, nasolabial, orbital, jowl, mental and submental regions.Facial volume compartments
Anatomical model: anAtomic “Lex” Ecorche Bust by Kent Trammell / CG Cookie. Adapted for web presentation by Dagan MD.
Injectables, reframed
A little science. A lot less mystery.
The quick version is always visible. Open a chapter—and then click for more—when you want the beauty-editor deep dive.
Neuromodulator changes selected muscle activity.Filler places material within a chosen tissue plane.
BOTOX® Cosmetic · Dysport · Xeomin · DAXXIFY®
Movement, edited—not erased
These prescription medicines temporarily soften selected muscle activity. Think of them as volume control for a specific expression, not an eraser for the whole face.
BOTOX® Cosmetic and related products contain purified botulinum toxin type A. At the tiny nerve-to-muscle junctions reached by the injected dose, they temporarily reduce release of the signal that tells a muscle to contract. The muscle is still there; it simply pulls less strongly, allowing the skin above it to look calmer when you frown, squint or raise your brows. DAXXIFY® uses daxibotulinumtoxinA-lanm in a peptide-stabilized formulation without human serum albumin.
Placement is the plot twist. A thoughtful plan treats only selected muscles and balances them against their neighbors, so brows can still communicate and a smile still belongs to you. DAXXIFY® may appeal to someone who values a longer studied treatment interval, while a shorter-acting option may feel preferable when flexibility matters. The effect is local to the treated region, although unintended spread is possible and is part of the safety discussion.
BOTOX® Cosmetic
Estimated longevity
Up to 4 months
Treatment rhythm
Usually 1; maintenance varies
The character
Precise, familiar reference point for expression lines
Worth knowing
Treatments are temporary; labeled facial treatments are spaced at least 90 days apart.
Dysport
Estimated longevity
May last up to 5 months
Treatment rhythm
Usually 1; maintenance varies
The character
A different formulation and diffusion profile
Worth knowing
Its units cannot be converted directly from BOTOX or Xeomin units.
Xeomin
Estimated longevity
About 3–4 months
Treatment rhythm
Usually 1; maintenance varies
The character
A purified formulation without accessory proteins
Worth knowing
Still the same prescription toxin class, with similar precautions.
DAXXIFY®
Estimated longevity
Often discussed around 6 months; individual results vary
Treatment rhythm
Usually 1; do not repeat more often than every 3 months
The character
A peptide-stabilized daxibotulinumtoxinA-lanm formulation without human serum albumin
Worth knowing
FDA approved for temporary improvement of moderate-to-severe glabellar lines in adults. In pivotal studies, more than half had none or mild frown lines at 24 weeks. Units cannot be compared or converted directly from another toxin.
Why patients consider it
Softens movement-led lines without adding facial volume
One brief treatment session for most plans
Product choice can support either flexibility or a longer maintenance interval
Dose and placement can be adjusted at future visits
Useful when the concern appears mainly with expression
The tradeoffs
Temporary and requires repeat treatment to maintain
Units are not interchangeable among brands
A longer-lasting product can also mean an unwanted effect takes longer to fade
May cause headache, bruising, asymmetry or temporary eyelid/brow droop
Rare spread of toxin effect can cause serious swallowing, speaking or breathing problems
Hyaluronic-acid commercial families
The most versatile texture wardrobe
Hyaluronic acid, or HA, is a water-loving sugar already found in the body. In filler form it becomes a family of gels—from soft and silky to firm and architectural.
Cross-linking turns HA into a gel that can hold shape long enough to support a lip border, soften a fold, restore cheek structure or refine a chin and jawline. Softer gels tend to move naturally in mobile areas; firmer gels are chosen when projection or deeper support matters. The commercial name is only the beginning: the exact formulation, treatment plane and amount determine how the product behaves.
The best HA work reads as better proportion, not more product. HA can often be reduced with hyaluronidase when medically appropriate, but dissolving is another treatment—not a magic undo button—and has its own limitations and risks.
RESTYLANE® family
Estimated longevity
Approximately 6–18 months depending on the exact product and treatment area
Treatment rhythm
Often one treatment plus a 2-week review; staged correction may be safer than adding too much at once
The character
A wide HA portfolio with both firmer NASHA® gels for precision and projection and flexible XpresHAn Technology™ gels designed to move with expression
Worth knowing
The products are not interchangeable. Eyelight, Kysse, Lyft, Contour, Refyne, Defyne, Restylane® and Silk have different textures, depths and approved uses.
Best considered for
Matching a very specific job to a specific gel—from subtle under-eye or lip refinement to cheek, chin, fold or hand support.
Texture + behavior
Ranges from delicate and flexible to firm and highly supportive.
Can it be reversed?
Usually reducible with hyaluronidase when clinically appropriate; response is not perfectly predictable and more than one session may be needed.
Restylane® Kysse — lip shape, color and flexible movement
Restylane® Lyft — cheek structure and dorsal hand volume
Restylane® Contour — cheek definition and shape
Restylane® Defyne — chin definition and deeper folds
Restylane® Refyne — dynamic smile lines and flexible support
Restylane® / Restylane®-L — lips and moderate-to-severe facial folds
Restylane® Silk — subtle lip enhancement and perioral lines
Advertised or clinically studied longevity
Approximate planning window—not a promise. “Up to” describes a study or manufacturer endpoint with optimal treatment, not the average result for every patient.
Restylane® Eyelight · under-eyesUp to 18 monthsManufacturer-advertised satisfaction and improvement through 18 months with optimal treatment.Restylane® Contour · cheeksUp to 18 monthsClinical-study window for midface cheek contour.Restylane® Kysse · lipsUp to 12 monthsClinical-study window for lip treatment.Restylane® Defyne · folds or chinUp to 12 monthsClinical-study window for facial folds and chin augmentation.Restylane® Refyne · facial foldsUp to 12 monthsClinical-study window for nasolabial folds and marionette lines.Restylane® Lyft · cheeksUp to 12 monthsClinical-study window for cheek fullness.Restylane® Lyft · folds or handsUp to 6 monthsClinical-study window differs from cheek treatment because the area and use are different.Restylane® / Restylane®-L · facial foldsUp to 18 monthsManufacturer summary of clinical studies for wrinkles and folds; lip duration may be shorter.Restylane® Silk · lips or perioral linesUp to 6 monthsClinical-study window for lip enhancement and lines around the mouth.
Particular strengths
One of the broadest texture ranges in a single HA family
XpresHAn products emphasize flexibility in expressive areas
NASHA products emphasize precision, shape and projection
Immediate correction with no donor-site procedure
Limitations + cautions
Duration cannot be predicted from brand name alone
A product suited to the cheek may be inappropriate for the lips or under-eyes
Water attraction can create temporary swelling or an overfull early appearance
All HA fillers share rare but serious vascular-occlusion risk
JUVÉDERM® Collection
Estimated longevity
Approximately 12–24 months depending on the exact product and treatment area
Treatment rhythm
Often one treatment with an optional review or conservative touch-up after settling
The character
A collection of smooth HA gels ranging from soft lip and under-eye correction to stronger cheek, chin, temple and jawline projection
Worth knowing
VOLUMA, VOLUX, VOLLURE, VOLBELLA, Ultra XC and Ultra Plus XC are designed for different anatomical jobs and should not be treated as one generic gel.
Best considered for
Patients who need a smooth HA option chosen by region: lips, perioral lines, folds, under-eyes, cheeks, chin, temples or jawline.
Texture + behavior
Generally smooth and cohesive, with firmness increasing in the products designed for deeper structure.
Can it be reversed?
Usually reducible with hyaluronidase when appropriate, although dissolving cannot guarantee an exact return to the pretreatment state.
Products and practical differences
JUVÉDERM® VOLUMA® XC — cheeks, chin and temple augmentation
JUVÉDERM® VOLBELLA® XC — lips, perioral lines and under-eye hollows
JUVÉDERM® Ultra XC — lip augmentation and facial folds
JUVÉDERM® Ultra Plus XC — deeper facial folds
Advertised or clinically studied longevity
Approximate planning window—not a promise. “Up to” describes a study or manufacturer endpoint with optimal treatment, not the average result for every patient.
JUVÉDERM® VOLUMA® XC · cheeksUp to 24 monthsManufacturer-advertised duration with optimal cheek treatment.JUVÉDERM® VOLUMA® XC · templesUp to 13 monthsManufacturer-advertised duration with optimal temple treatment.JUVÉDERM® VOLUMA® XC · chinUp to 12 monthsManufacturer-advertised duration with optimal chin treatment.JUVÉDERM® VOLUX® XC · jawlineUp to 12 monthsManufacturer-advertised duration with optimal jawline treatment.JUVÉDERM® VOLLURE® XC · facial foldsUp to 18 monthsClinical-study and manufacturer-advertised window for smile lines.JUVÉDERM® VOLBELLA® XC · lips or under-eyesUp to 12 monthsManufacturer-advertised duration with optimal treatment in either labeled area.JUVÉDERM® Ultra XC · lipsUp to 12 monthsManufacturer-advertised duration with optimal lip treatment.JUVÉDERM® Ultra Plus XC · facial foldsUp to 12 monthsManufacturer-advertised duration with optimal treatment of smile lines.
Particular strengths
Six distinct fillers designed for different facial areas
Immediate support with a range from softness to structural projection
Longer studied duration for selected deep structural products
HA reversibility provides more flexibility than non-HA materials
Limitations + cautions
Smooth does not mean suitable for every tissue plane
Longer-lasting structural gels can be less forgiving of overcorrection
Swelling can be especially noticeable in lips and under-eyes
All injections require an emergency plan for vascular compromise
BELOTERO BALANCE® (+)
Estimated longevity
Approximately 6–12 months depending on formulation, treatment area and individual tissue behavior
Treatment rhythm
Usually one conservative session with reassessment after swelling settles
The character
A cohesive HA gel designed to integrate smoothly within facial tissue, particularly where mobility and surface visibility make a bulky edge undesirable
Worth knowing
It remains a dermal filler with the same need for anatomy-aware placement and vascular-risk preparedness; a fine texture does not make injection risk-free.
Soft, cohesive and tissue-integrating rather than heavily projecting.
Can it be reversed?
Usually reducible with hyaluronidase when clinically appropriate.
Products and practical differences
BELOTERO BALANCE® — HA gel without lidocaine
BELOTERO BALANCE® (+) — the same core HA platform with lidocaine for injection comfort
Advertised or clinically studied longevity
Approximate planning window—not a promise. “Up to” describes a study or manufacturer endpoint with optimal treatment, not the average result for every patient.
BELOTERO BALANCE® · nasolabial foldsAbout 6 monthsU.S. patient guide reports the filling effect lasting about 6 months, with gradual fading.BELOTERO BALANCE® (+) · facial foldsAbout 9–12 monthsIn the lidocaine-formulation clinical study, results lasted beyond 48 weeks in a majority of subjects; individual duration varies.
Particular strengths
Designed for smooth integration in mobile, high-visibility areas
Useful when refinement is more important than dramatic projection
Can address relatively superficial lines without choosing a firmer structural gel
HA-based and therefore generally more adjustable than biostimulators or PMMA
Limitations + cautions
Not the first choice when strong skeletal projection is the main goal
Fine placement still can produce swelling, contour irregularity or a bluish surface cast if too superficial
Longevity varies and may be shorter in highly mobile areas
Shares the rare vascular risks of every facial filler injection
Why patients consider it
The broadest range of softness, lift, flexibility and projection
Immediate visible support followed by settling as swelling resolves
Options for lips, cheeks, chin, jawline, folds, temples and selected under-eye concerns
The only major filler class that can usually be enzymatically reduced with hyaluronidase
The tradeoffs
Swelling, bruising, tenderness and temporary asymmetry are common
Maintenance and occasional staged refinement are expected
Lumps, nodules, migration or delayed inflammatory reactions can occur
Rare vascular occlusion can injure skin and, in some facial areas, threaten vision or cause stroke
RADIESSE® / RADIESSE® (+)
Structure now, collagen conversation later
Radiesse® is a firmer calcium-based injectable that gives immediate support, then leaves a scaffold that can encourage collagen and elastin production as its gel carrier fades.
Microscopic calcium hydroxylapatite spheres sit in a smooth gel. Depending on concentration and placement, the material may be used for structural contour, selected facial folds, hand volume or—under a specific plan—more diffuse skin-quality support. It is not the right texture for every delicate or highly mobile area.
Expect more framework than gloss: a jawline, lower-face contour or hand can look less skeletal without asking the product to behave like a soft lip gel.
RADIESSE® / RADIESSE® (+)
Estimated longevity
Approximately 12–24 months in facial use; hand correction is commonly studied through about 12 months
Treatment rhythm
Often one carefully placed session; dilute skin-quality protocols may be staged
The character
Calcium hydroxylapatite microspheres in a gel carrier provide immediate framework and a signal for collagen and elastin remodeling
Worth knowing
RADIESSE (+) contains lidocaine. Undiluted, dilute and hyperdilute use behave differently and are not interchangeable treatment plans.
Best considered for
Selected lower-face folds, pre-jowl or jawline support, dorsal hand volume and carefully selected broader skin-quality applications.
Texture + behavior
Firm and structural when used in standard concentration; more diffuse when deliberately diluted for a different tissue goal.
Can it be reversed?
Not dissolved by hyaluronidase. Management of an unwanted result is more involved than with HA filler.
Products and practical differences
RADIESSE® — CaHA microspheres in a carboxymethylcellulose gel carrier
RADIESSE® (+) — the CaHA platform with lidocaine
Dilute or hyperdilute RADIESSE — a clinician-directed change in concentration for broader tissue treatment; not a separate commercial product
Advertised or clinically studied longevity
Approximate planning window—not a promise. “Up to” describes a study or manufacturer endpoint with optimal treatment, not the average result for every patient.
RADIESSE® / RADIESSE® (+) · faceAbout 12–24 monthsMany patients are counseled around a year or longer; the manufacturer reports results shown to last up to 2 years.RADIESSE® · dorsal handsAbout 9–12 monthsClinical and safety information commonly follows hand results through 1 year.Dilute or hyperdilute RADIESSE · skin qualityAbout 12–24 monthsA planning estimate based on gradual collagen remodeling; protocol, concentration, area and number of sessions materially change duration.
Particular strengths
Combines immediate contour with biostimulatory activity
Particularly useful when framework is needed rather than lip-like softness
FDA-labeled uses include selected facial folds, dorsal hands and jawline contour depending on formulation
Can be adapted by concentration for distinct structural or skin-quality goals
Limitations + cautions
Generally avoided in lips and other areas needing a very soft, mobile gel
Depth and distribution must be precise to reduce nodule risk
It cannot be casually dissolved after placement
Lumps, inflammation, infection and vascular complications remain possible
Why patients consider it
Immediate structural effect plus biostimulatory activity
Useful for selected lower-face contours and hand rejuvenation
May improve firmness and skin quality over time
Often completed in one session, with staging when appropriate
The tradeoffs
Not dissolved by hyaluronidase like HA filler
Requires exact depth and anatomy-aware placement
Can cause lumps or nodules, including in the hands
Duration and response vary; correction can be more involved than with HA
SCULPTRA® aesthetic injectable
A slow burn, not an instant fill
Sculptra® is a collagen stimulator. It is chosen for gradual, broad restoration—not for a one-visit lip or a tiny line that needs millimeter-level filling.
Poly-L-lactic acid particles are placed in a diluted suspension. The early water-related fullness fades, then the skin gradually builds collagen around the treatment pattern. The change appears over weeks, which is precisely why it can feel quietly convincing.
This is the long-game option: less ‘I got filler yesterday,’ more ‘my face seems to have found its structure again.’ It is often planned across the cheeks and facial frame rather than used as a spot corrector.
SCULPTRA® (PLLA-SCA)
Estimated longevity
Approximately 18–24 months after a completed treatment series; improvement develops gradually
Treatment rhythm
Commonly 2–3 sessions over several months; vial count and interval are individualized
The character
A suspended poly-L-lactic acid collagen stimulator that produces gradual, broad change rather than an immediate gel-shaped contour
Worth knowing
The fullness seen immediately after injection largely reflects diluent and recedes. The true result develops as collagen response evolves.
Best considered for
Diffuse facial deflation, cheek-region support, facial-frame continuity and selected skin-quality or jawline goals where gradual change is preferred.
Texture + behavior
Not a conventional gel. It is reconstituted into a suspension and distributed across a planned treatment field.
Can it be reversed?
Not dissolvable with hyaluronidase. Time, observation and problem-specific treatment are used if nodules or unwanted effects occur.
Products and practical differences
SCULPTRA® — the commercial PLLA-SCA collagen stimulator used in an individualized series; it is not a family of different gel strengths
Advertised or clinically studied longevity
Approximate planning window—not a promise. “Up to” describes a study or manufacturer endpoint with optimal treatment, not the average result for every patient.
SCULPTRA® · completed facial seriesAbout 18–24 monthsMost study participants began seeing change around 1 month, with improvement sustained for up to 2 years after an average 2–3-session series.
Particular strengths
A gradual result can integrate quietly across broad facial zones
May improve glow, firmness and contour as collagen develops
Long study window after a completed series
Does not rely on placing one large pocket of gel
Limitations + cautions
Requires patience and usually multiple visits
Not appropriate for lips, immediate spot correction or millimeter-level sculpting
The final response cannot be previewed immediately
Papules, nodules, granulomas and asymmetry are possible
Why patients consider it
Gradual change that can look subtle and integrated
Supports broader areas rather than one isolated crease
Results may persist up to 2 years in studied treatment plans
Useful when collagen support is the primary goal
The tradeoffs
Usually requires a series rather than one appointment
Results are delayed and less instantly predictable than HA
Not dissolved with hyaluronidase
Papules, nodules and granulomas are possible; massage and aftercare matter
BELLAFILL® · selected indications only
The commitment piece
Bellafill® pairs an immediate bovine-collagen carrier with tiny non-absorbable PMMA microspheres that remain as a structural scaffold. This is not a casual first date with filler.
The collagen gel creates early correction while the PMMA microspheres remain in place. FDA-approved uses include nasolabial folds and certain moderate-to-severe, distensible acne scars on the cheek in adults over 21. Because the material is long lasting and not readily reversible, conservative selection and exact placement are essential.
Bellafill® can offer enduring correction where its indication and tissue behavior make sense—but it trades easy reversibility for longevity.
BELLAFILL® (PMMA + bovine collagen)
Estimated longevity
About 12 months of studied acne-scar correction and 5 years of studied nasolabial-fold effectiveness; the PMMA itself is non-absorbable
Treatment rhythm
A skin test is performed first; treatment is conservative and may be staged after eligibility is confirmed
The character
The bovine-collagen carrier supplies early correction while non-absorbable PMMA microspheres remain as a long-term scaffold
Worth knowing
A negative Bellafill® skin test is required. It is not intended for lip augmentation and is less forgiving than a temporary HA gel.
Best considered for
FDA-labeled correction of nasolabial folds and selected moderate-to-severe, atrophic, distensible cheek acne scars in adults over 21.
Texture + behavior
A collagen-based injectable containing smooth PMMA microspheres rather than a dissolving HA gel.
Can it be reversed?
Not dissolved by hyaluronidase and not considered readily reversible. Removal of misplaced permanent material can be difficult or incomplete.
Products and practical differences
BELLAFILL® — the U.S. commercial PMMA microsphere and bovine-collagen filler; there is no softer or readily reversible Bellafill® variant
Advertised or clinically studied longevity
Approximate planning window—not a promise. “Up to” describes a study or manufacturer endpoint with optimal treatment, not the average result for every patient.
BELLAFILL® · nasolabial folds5 years studiedEffectiveness and patient satisfaction have been established through 5 years; that endpoint is not a guarantee beyond 5 years.BELLAFILL® · eligible cheek acne scars12 months studiedThe approved acne-scar studies establish correction through 12 months; the non-absorbable PMMA microspheres remain in tissue.
Particular strengths
Immediate correction plus unusually long structural persistence
Five-year safety and effectiveness follow-up exists for nasolabial folds
Can address an eligible distensible acne scar rather than only facial volume
May reduce the frequency of maintenance for an exceptionally well-selected patient
Limitations + cautions
Requires advance bovine-collagen skin testing and an additional planning interval
Permanent support may not age with changing anatomy or preferences
Delayed papules, nodules or granulomas can be persistent
Severe allergies, bovine collagen allergy, lidocaine allergy, bleeding disorders and problematic scar tendency require careful exclusion
Why patients consider it
Immediate correction from the collagen carrier
Long-lasting structural support
Five-year follow-up data exist for nasolabial-fold treatment
An option for carefully selected folds or eligible acne scars
The tradeoffs
Required skin testing because it contains bovine collagen
Non-absorbable and not readily reversible
Less forgiving of changing preferences, aging or imperfect placement
Can cause delayed nodules, granulomas or other long-term complications
alloClae™ · body contouring
A tissue-based option—not another facial filler
alloClae is a ready-to-use allograft made from donated human adipose tissue. It is placed beneath the skin in localized body areas where fat naturally provides cushioning and support. Unlike fat transfer, it does not require liposuction or harvesting your own fat.
The manufacturer describes alloClae as non-living fat cells, extracellular matrix, lipids and connective tissue processed to preserve adipose tissue’s natural three-dimensional structure. It is marketed as a Human Cell and Tissue Product (HCT/P), not as an FDA-approved dermal filler. The treatment conversation is therefore about small, targeted body-contour refinements—not substituting it for a familiar hyaluronic-acid facial gel.
Think subtle support rather than a dramatic implant: restoring a small contour deficit, softening a visible irregularity or refining symmetry in an area where fat normally belongs. The amount, tissue plane and limits should be mapped as carefully as the desired shape.
alloClae™
Estimated longevity
Potentially lasting; individual duration varies
Treatment rhythm
One carefully planned placement; reassessment is individualized
The character
Donor-derived adipose tissue matrix for localized subcutaneous cushioning and support
Worth knowing
This is a body-contouring HCT/P, not a synthetic facial filler or a source of living stem cells. Product-specific consent and candidacy review are essential.
Why patients consider it
No liposuction or donor-site recovery is required
Ready-to-use material for localized, in-office treatment
Immediate contour support, with little downtime reported by the manufacturer
May be considered when a patient has too little donor fat for traditional fat transfer
The tradeoffs
It is donor human tissue and does not contain viable cells
Longevity varies by body, placement and lifestyle; lasting does not mean guaranteed or permanent
Not for active infection, severe allergen sensitivities or a history of anaphylaxis
Potential complications include cysts or nodules, pain, infection, hematoma, immune or allergic response and skin discoloration
Commercial names identify product families discussed for patient education; they do not mean that every formulation is appropriate, available, or recommended for every person. The exact product, amount, tissue plane and labeled or off-label use are reviewed before treatment.
About longevity: the detailed profiles use manufacturer-advertised and clinically studied windows to provide a practical estimate for each formulation and treatment area. “Up to” is a study endpoint, not a guaranteed duration or an average. Product, dose, treatment area, metabolism, anatomy, movement and technique all affect how long a visible change lasts.
All injectables and allografts can cause adverse effects. Dermal filler has rare but serious vascular risks, including tissue injury, vision loss and stroke. Neuromodulators carry product-specific warnings, including rare spread of toxin effect. alloClae is marketed as an HCT/P and should not be described as an FDA-approved dermal filler. Exact product status, intended use, alternatives, tissue-source considerations and emergency planning are reviewed during consultation.
Madison Avenue · New York City
Ready when you are.
Meet Dr. Dagan in person or begin with a virtual consultation.
DAGAN MD